We believe that there is a significant opportunity to help improve mental health and wellbeing for millions of people globally

Psyence is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing.

Our vision is that our enduring work expands access to mental wellness and nurtures community. We will achieve this by developing and providing innovative, safe and effective psychedelic and nature-centred solutions for mental health and palliative care.

Psyence is developing proprietary natural psilocybin drug development and treatment protocols with a focus on palliative care

The current treatments available for adjustment disorder associated with a terminal diagnosis are lacking. While antidepressant medication can be effective it can also diminish quality of life. Research has shown that natural psilocybin drugs are safe and effective and allow for a better quality of life.

Our natural psilocybin mushrooms

Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to be processed into a standardised encapsulated product.

We believe that the growing consumer demand for nature-based medicine and plant-based products, may incentivise the use of natural psilocybin as a therapeutic agent. The psilocybin molecule from natural sources is the same as synthetically derived products. However, the natural sourced product has other similar acting molecules to psilocybin, which may have synergistic and desirable effects.

Natural Psilocybin - Psyence

Our natural psilocybin mushrooms

Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to be processed into a standardised encapsulated product.

We believe that the growing consumer demand for nature-based medicine and plant-based products, may incentivise the use of natural psilocybin as a therapeutic agent. The psilocybin molecule from natural sources is the same as synthetically derived products. However, the natural sourced product has other similar acting molecules to psilocybin, which may have synergistic and desirable effects.

Our Team

JODY AUFRICHTIG | Psyence | Psilocybin

Jody Aufrichtig

Co-Founder, Executive Chairman and Director

Our Team

Dr. Neil Maresky

Chief Executive Officer

Our Team

Tony Budden

Chief Strategy Officer

Neil Van Rij - Psyence - Mycologist

Neil Van Rij

Mycologist

Our Team

Dr. Justin Grant

Chief Scientific Officer

Our Team

Taryn Vos

General Counsel

WARWICK_CORDEN-LLOYD

Warwick Corden-Lloyd

Chief Financial Officer

Our Team

Alan Friedman

Capital Markets Advisor and Director

Our Team

Xan Morgan

European Director and Advisory Board Member

Gavin Basserabie | Psyence Group

Gavin Basserabie

Independent Director

Our Team

Mary-Elizabeth Gifford

EVP, Public Affairs and Corporate Social Responsibility

Our Team

Marvin Singer

Independent Director

Our Team

Dr. Clive Ward-Able

Medical Director

Our Team

Jean-Mari Conradie

Quality Assurance Manager